首页> 外文期刊>Journal of the American Pharmacists Association: JAPhA >Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.
【24h】

Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.

机译:药剂师和技术人员对将丁丙诺啡/纳洛酮分配给阿片类药物依赖患者的看法和态度。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To assess the perceptions and attitudes of pharmacists and pharmacy technicians involved in an office-based opioid dependence treatment program using buprenorphinealoxone. DESIGN: Cross-sectional attitudinal assessment. SETTING: Community, outpatient hospital, and clinic pharmacies. PARTICIPANTS: Pharmacists and technicians participating in a clinical trial of opioid dependence treatment using buprenorphinealoxone. INTERVENTION: Written and telephone surveys followed by interviews with open-ended items. MAIN OUTCOME MEASURES: Attitudes and perceptions regarding opioid-dependent patients and use of buprenorphinealoxone for treatment of opioid dependence. RESULTS: Pharmacies in seven states (New York, Virginia, Illinois, Florida, Texas, California, and Washington) participated in the clinical trial. A total of 40 pharmacists and pharmacy technicians responded to the initial written survey, representing 27 of the 32 pharmacies (84%). Follow-up interviews were obtained from one individual at 30 of those pharmacies (93.8%). Most pharmacy personnel (77.5%) involved with this study were not more concerned about theft or break-ins and would be willing to participate in opioid dependence treatment as the medication became available commercially (70%). The majority of respondents (85%) indicated that patients did not cause problems at their pharmacies. Compared with their experiences in administering other narcotic medications, most respondents did not express increased concern regarding prescription forgery (75%) or diversion (80%) of buprenorphinealoxone. CONCLUSION: The majority of respondents expressed positive attitudes and perceptions regarding patients treated for opioid dependence with buprenorphinealoxone.
机译:目的:评估参与使用丁丙诺啡/纳洛酮的基于办公室的阿片类药物依赖治疗计划的药剂师和药学技术人员的看法和态度。设计:横断面态度评估。地点:社区,门诊医院和诊所药房。参与者:参与使用丁丙诺啡/纳洛酮进行阿片类药物依赖治疗的临床试验的药剂师和技术人员。干预:书面和电话调查,然后与不限成员名额项目进行访谈。主要观察指标:对阿片类药物依赖患者的态度和看法,以及丁丙诺啡/纳洛酮在治疗阿片类药物依赖方面的态度。结果:七个州(纽约,弗吉尼亚州,伊利诺伊州,佛罗里达州,德克萨斯州,加利福尼亚州和华盛顿州)的药房参加了该临床试验。最初的书面调查共有40位药剂师和药房技术人员回答,占32家药房中的27家(占84%)。对其中30家药房的一名个体进行了随访访谈(93.8%)。参与这项研究的大多数药房人员(77.5%)并不更担心盗窃或闯入,并愿意参加阿片类药物依赖治疗,因为该药已经商业化销售(70%)。大多数受访者(85%)表示患者在药房没有引起任何问题。与他们使用其他麻醉药品的经验相比,大多数受访者并未对丁丙诺啡/纳洛酮的处方伪造(75%)或转移(80%)表示担忧。结论:大多数受访者对接受丁丙诺啡/纳洛酮治疗阿片类药物依赖的患者表示积极的态度和看法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号